Punding and dyskinesias
- 29 September 2006
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 21 (12), 2214-2217
- https://doi.org/10.1002/mds.21118
Abstract
The presence of punding in Parkinson's disease (PD) has been associated with inappropriate excessive use of dopaminergic medication but its relation to the severity of dyskinesias is not known. Through the use of clinical examination and medical chart review, the presence of punding and the severity of interdose dyskinesias were evaluated by two different observers. Punding was associated with more frequent interventions to reduce dyskinesias and with greater dyskinesia severity. We suggest the neural systems mediating the expression of dyskinesias and punding might overlap and that punding should be looked for systematically in PD patients presenting with disabling severe dyskinesias. © 2006 Movement Disorder SocietyThis publication has 25 references indexed in Scilit:
- Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson's diseaseNeuropharmacology, 2005
- Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's diseaseMovement Disorders, 2004
- Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorderMovement Disorders, 2004
- Effect of the D3 Dopamine Receptor Partial Agonist BP897 [N-[4-(4-(2-Methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on l-3,4-Dihydroxyphenylalanine-Induced Dyskinesias and Parkinsonism in Squirrel MonkeysThe Journal of pharmacology and experimental therapeutics, 2004
- Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndromeMovement Disorders, 2004
- Adenosine receptors and l-DOPA-induced dyskinesia in Parkinson's disease: potential targets for a new therapeutic approachExperimental Neurology, 2003
- Disabling repetitive behaviors in Parkinson's diseaseMovement Disorders, 2003
- Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long‐term follow‐up study of 64 patientsMovement Disorders, 2002
- Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapiesJournal of Neurology, Neurosurgery & Psychiatry, 2000
- The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seekingBrain Research Reviews, 1999